Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus.

MLA

Vanheule, Vincent, et al. “Basic Chemokine-Derived Glycosaminoglycan Binding Peptides Exert Antiviral Properties against Dengue Virus Serotype 2, Herpes Simplex Virus-1 and Respiratory Syncytial Virus.” Biochemical Pharmacology, vol. 100, Jan. 2016, pp. 73–85. EBSCOhost, https://doi.org/10.1016/j.bcp.2015.11.001.

APA

Vanheule, V., Vervaeke, P., Mortier, A., Noppen, S., Gouwy, M., Snoeck, R., Andrei, G., Van Damme, J., Liekens, S., & Proost, P. (2016). Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus. Biochemical Pharmacology, 100, 73–85. https://doi.org/10.1016/j.bcp.2015.11.001

Chicago

Vanheule, Vincent, Peter Vervaeke, Anneleen Mortier, Sam Noppen, Mieke Gouwy, Robert Snoeck, Graciela Andrei, Jo Van Damme, Sandra Liekens, and Paul Proost. 2016. “Basic Chemokine-Derived Glycosaminoglycan Binding Peptides Exert Antiviral Properties against Dengue Virus Serotype 2, Herpes Simplex Virus-1 and Respiratory Syncytial Virus.” Biochemical Pharmacology 100 (January): 73–85. doi:10.1016/j.bcp.2015.11.001.